Epygenix Therapeutics Announces Appointment of Darren Cline as CEO

Mar 15, 2022

PARAMUS, N.J. - March 15, 2022 - (Newswire.com)

Epygenix Therapeutics, a clinical-stage biopharmaceutical company developing drugs for rare and intractable forms of genetic epilepsy, announces the appointment of Darren Cline as President and Chief Executive Officer and also Director of the Board. Mr. Cline will succeed Hahn-Jun Lee, M.Sc., Ph.D., who will continue serving on the Board of Directors and working as a transitionary advisor to the new CEO. 

Mr. Cline is a seasoned pharmaceutical industry executive with an over-30-year track record of building key commercial organizations and functions. He is continuing his commitment to support patients and families of rare genetic epilepsies. "We are very excited for Darren to join our team, which will bring immediate synergies and be a critical catalyst for our commercialization efforts in highly unmet, rare epilepsy areas," said Alex Yang, JD, LLM, Chair and Executive Director of the Board at Epygenix.

Before joining Epygenix, Mr. Cline was most recently the US Chief Commercial Officer at GW Pharmaceuticals, where he led the successful commercialization of Epidiolex for rare epilepsies, which helped lead to the company's $7.2 billion acquisition by Jazz Pharmaceuticals in 2021. Before that, he was Executive Vice President, Commercial at Seagen, where he was responsible for the commercialization of ADCETRIS in the United States and Canada. Mr. Cline also held commercial leadership roles at Intermune, Alexion Pharmaceuticals, and Amgen. He is currently a member of the Pyxis Oncology Board of Directors and was formerly on the Stemline Therapeutics Board of Directors.

"Darren will add significant value to Epygenix with his seasoned experience in the commercialization of Epidiolex. He will lead the growth of the company from the clinical to commercial stage. Epygenix greatly welcomes him on board," commented Hahn-Jun Lee, M.Sc., Ph.D., a co-founder and Executive Director of Epygenix's Board.

"Darren knows the rare epilepsy disease space intimately and his established relationships in this space will open new opportunities for Epygenix. I am confident Darren's leadership will help bring safe and effective therapies to our patients," said Scott Baraban, Ph.D., a co-founder, Chair of the Scientific Advisory Board and Director of the Board at Epygenix. 

"I am proud and honored to join Epygenix," said Mr. Cline. "The company has an extraordinary opportunity to leverage its unique platform to bring transformational therapies to patients who live with rare genetic epilepsies. I look forward to leading the company as it transitions into its next phase of clinical development and future commercialization."

About Epygenix Therapeutics, Inc.

Epygenix Therapeutics, Inc. is a precision medicine-based biopharmaceutical company focused on discovering and developing drugs to treat rare and intractable forms of genetic epilepsy in childhood, such as Dravet Syndrome. Epygenix is currently focused on developing EPX-100, EPX-200, and EPX-300. These drug candidates abolish convulsive behavior and electrographic seizure activity and were discovered in a zebrafish Dravet Syndrome model, which mimics the human pathology. For more information, please visit www.epygenix.com.

Media Contact 

Andrew O

[email protected] 




Press Release Service by Newswire.com

Original Source: Epygenix Therapeutics Announces Appointment of Darren Cline as CEO

More News

'President will talk to anyone, anywhere, to advocate for American interests': JD Vance on Trump-Putin meeting in Shenzhen
Nov 20, 2026
'President will talk to anyone, anywhere, to advocate for American interests': JD Vance on Trump-Putin meeting in Shenzhen

JD Vance defended President Donald Trump's diplomatic engagement with Russian President Vladimir Putin regarding American interests. The discussion included the potential for reforming the United Nations during a trilateral meeting with Chinese President Xi Jinping. Their gathering focused on significant global challenges such as security and energy cooperation. Following these discussions, a joint declaration was adopted to enhance the UN's effectiveness in maintaining peace.

Everyone is a friend: Trump's meetings in Asia show his varied approaches to shifting world order
Nov 20, 2026
Everyone is a friend: Trump's meetings in Asia show his varied approaches to shifting world order

Donald Trump’s meetings with Quad partners India, Japan and Australia, followed by an unprecedented trilateral summit with China’s Xi Jinping and Russia’s Vladimir Putin, showcased contrasting strands of US foreign policy. While the Quad reaffirmed cooperation among democracies, the three-power meeting raised questions about an emerging world order.

Dawood Ibrahim-linked gangster Naseem Durrani shot dead in Uttar Pradesh encounter
Nov 20, 2026
Dawood Ibrahim-linked gangster Naseem Durrani shot dead in Uttar Pradesh encounter

Naseem Durrani, a gangster allegedly connected to underworld don Dawood Ibrahim, was killed in an encounter. He was suspected of involvement in the November 16 murder of Sameer outside a minister's office. Police tracked Durrani's movements due to his criminal history with approximately 25 cases registered. The joint operation was conducted by Delhi Police and Noida STF in Bulandshahr, Uttar Pradesh. Durrani's affiliations included links with noted gangster Chhota Shakeel.

Dawood Ibrahim-linked gangster Naseem Durrani shot dead in Uttar Pradesh encounter
Nov 20, 2026
Dawood Ibrahim-linked gangster Naseem Durrani shot dead in Uttar Pradesh encounter

Naseem Durrani, a gangster allegedly connected to underworld don Dawood Ibrahim, was killed in an encounter. He was suspected of involvement in the November 16 murder of Sameer outside a minister's office. Police tracked Durrani's movements due to his criminal history with approximately 25 cases registered. The joint operation was conducted by Delhi Police and Noida STF in Bulandshahr, Uttar Pradesh. Durrani's affiliations included links with noted gangster Chhota Shakeel.

Trump administration urges judge to lift order blocking Kennedy Center's two-year closure
Nov 20, 2026
Trump administration urges judge to lift order blocking Kennedy Center's two-year closure

President Donald Trump's administration is asking a federal judge to lift a block on the Kennedy Center renovations. U.S. District Judge Christopher Cooper had previously ruled against the board's decision to close the center for repairs. The board's actions were deemed ill-informed and lacking legal regard by the judge in May. Representative Joyce Beatty is challenging these renovation plans, citing mismanagement and potential future breaches.

Landfall process of Cyclone Akvan commences near Gopalpur in Odisha
Nov 20, 2026
Landfall process of Cyclone Akvan commences near Gopalpur in Odisha

The wind speed at the commencement of the landfall was 70-90 kmph and the same wind speed will continue for the next six hours

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Daily World Feed

Get yourself immersed in engaging topics right here. Daily World Feed is a multi-platform media, providing you latest breaking news straight from the industry.

Sign Up